Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality

Liver International

Volumn 32, Issue 1, 2012, Pages 158-164

  Brandman, Danielle ^a   Biggins, Scott W ^b   Hameed, Bilal ^a   Roberts, John P ^a   Terrault, Norah A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Altered mental status; Hyponatremia; Length of stay

Indexed keywords

SODIUM;

ADULT; ARTICLE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERNATREMIA; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; ORGAN DONOR; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; RISK ASSESSMENT; SODIUM BLOOD LEVEL; SURVIVAL;

CALIFORNIA; CARCINOMA, HEPATOCELLULAR; END STAGE LIVER DISEASE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; HYPONATREMIA; LENGTH OF STAY; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SODIUM;

EID: 83255181957     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02618.x     Document Type: Article

References (27)

1. Scientific Registry of Transplant Recipients. Available at (accessed 1 April 2010).
2. Cholongitas E, Marelli L, Shusang V, et al. A systematic review of the performance of the model for end stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006; 12: 1049-61.
3. Kamath PS, Wiesner RH, Malinchoc M, et al. Model to predict survival in patients with end stage liver disease. Hepatology 2001; 33: 464-70.
4. Dhar R, Young GB, Marotta P. Perioperative neurological complications after liver transplantation are best predicted by pre-transplant hepatic encephalopathy. Neurocrit Care 2008; 8: 253-8.
5. Sotil E, Gottstein, Ayala E, Randolph C, Blei AT. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transpl 2009; 15: 184-92.
6. Saner F, Gu Y, Minouchehr S, et al. Neurological complications after cadaveric and living donor liver transplantation. J Neurol 2006; 253: 612-7.
7. Ghaus N, Bohlega S, Rezeig M. Neurological complications in liver transplantation. J Neurol 2001; 248: 1042-8.
8. Senzolo M, Pizzolato G, Ferronato C, et al. Long-term evaluation of cognitive function and cerebral metabolism in liver transplanted patients. Transpl Proc 2009; 41: 1295-6.
9. Angeli P, Wong F, Watson H, Gines P. Hyponatremia in cirrhosis: results of a patient popuation survey. Hepatology 2006; 44: 1535-42.
10. Abbasoglu O, Goldstein RM, Vodapally MS, et al. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clin Transplant 1998; 12: 263-9.
11. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005; 41: 32-9.
12. Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-26.
13. Yun BC, Kim WR, Benson JT, et al. Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology 2009; 49: 1610-5.
14. Dawwas MF, Lewsey JD, Neuberger JM, Gimson AE. The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study. Liver Transpl 2007; 13: 1115-24.
15. Londono MC, Guevara M, Rimola A, et al. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology 2006; 13: 1135-43.
16. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wofe RA. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307-13.
17. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-21.
18. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-90.
19. Axelrod DA, Schnitzler M, Salvalaggio PR, Swindle J, Abe-cassis MM. The economic impact of the utilization of liver allografts with high donor risk index. Am J Transplant 2007; 7: 990-7.
20. Washburn WK, Meo NA, Halff GA, Roberts JP, Feng S. Factors influencing liver transplant length of stay at two large-volume transplant centers. Liver Transpl 2009; 15: 1570-8.
21. Earl TM, Cooil B, Rubin JE, Chari RS. Cost prediction in liver transplantation using pretransplant donor and recipient characteristics. Transplantation 2008; 86: 238-44.
22. Garcia-Martinez R, Rovira A, Alonso J, et al. Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume. Liver Transpl 2011; 17: 38-46.
23. Burkhalter EL, Starzl TE, Van Thiel DH. Severe neurological complications following orthotopic liver transplantation in patients receiving FK 506 and prednisone. J Hepatol 1994; 21: 572-7.
24. DiMartini A, Fontes P, Dew MA, Lotrich FE, de Vera M. Age, model for end-stage liver disease score, and organ functioning predict posttransplant tacrolimus neurotoxicity. Liver Transpl 2008; 14: 815-22.
25. Guevara M, Baccaro ME, Torre A, et al. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. Am J Gastroenterol 2009; 104: 1382-9.
26. Palevsky PM, Bhagrath R, Greenberg A. Hypernatremia in hospitalized patients. Ann Intern Med 1996; 124: 197-203.
27. Laureno R, Karp BI. Myelinolysis after correction of hyponatremia. Ann Intern Med 1997; 126: 57-62.